The cost implications of off-pump versus on-pump coronary artery bypass graft surgery at one year
Jazyk angličtina Země Nizozemsko Médium print-electronic
Typ dokumentu srovnávací studie, časopisecké články, multicentrická studie, randomizované kontrolované studie, práce podpořená grantem
Grantová podpora
85214
Canadian Institutes of Health Research - Canada
PubMed
25261272
DOI
10.1016/j.athoracsur.2014.06.046
PII: S0003-4975(14)01330-7
Knihovny.cz E-zdroje
- MeSH
- analýza nákladů a výnosů MeSH
- časové faktory MeSH
- koronární bypass bez mimotělního oběhu ekonomika MeSH
- koronární bypass ekonomika MeSH
- lidé středního věku MeSH
- lidé MeSH
- náklady na zdravotní péči MeSH
- nemoci koronárních tepen ekonomika chirurgie MeSH
- retrospektivní studie MeSH
- senioři MeSH
- Check Tag
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- multicentrická studie MeSH
- práce podpořená grantem MeSH
- randomizované kontrolované studie MeSH
- srovnávací studie MeSH
BACKGROUND: The purpose of this study was to determine the cost implications of the Coronary Artery Bypass Graft Off or On Pump Revascularization Study (CORONARY) at 1 year. METHODS: Country-specific healthcare costs were obtained from public databases or local experts from each country in the CORONARY trial. Purchasing power parities were applied to these costs of consumed healthcare resources. Analyses of subgroups included in the CORONARY clinical trial were also conducted. Costs are reported in US dollars. RESULTS: After 1 year, the total cost per patient in the off-pump coronary artery bypass graft surgery (CABG) arm was $9,650 ($9,216 to $10,285) compared with $9,583 ($9,239 to $9,988) for the on-pump CABG arm; that resulted in a nonsignificant increase of $68 (-$575 to $710). Similar findings were noted for various subgroups. There were also no differences due to late conversions. CONCLUSIONS: The CORONARY trial demonstrated that off-pump CABG was clinically as safe and effective as on-pump CABG with no difference in costs. Thus, the decision as to which method to choose is free from costs considerations and should be based on patient preference and surgeon expertise (Coronary Artery Bypass Graft [CABG] Off or On Pump Revascularization Study [CORONARY]; clinicaltrials.gov NCT00463294).
3rd Faculty of Medicine Charles University Prague Czech Republic
Ankara University School of Medicine Ankara Turkey
Nuffield Department of Surgical Sciences University of Oxford Oxford United Kingdom
Population Health Research Institute McMaster University Hamilton Ontario Canada
Unidade de Terapia Intensiva Hospital do Coração São Paulo Brazil
Citace poskytuje Crossref.org
ClinicalTrials.gov
NCT00463294
